Abstract
1. The metabolic fate of 3,5-diiodo-4-(4′-acetoxy-3′-[125I]iodophenoxy)-benzoic acid was studied in rats and its principal metabolites identified.2. The drug, orally administered, was rapidly and almost quantitatively absorbed from the intestine, and was distributed to liver and kidney. Blood levels of radioactivity reached a plateau 3 to 5 h after administration, and gradually decreased. Radioactivity was rapidly excreted, largely in the bile, and entered into entero-hepatic circulation. Subsequent excretion in faeces and urine, amounted to 60 and 25%, respectively, within 72 h.3. Repeated oral administration of the drug did not show any accumulation, except in the thyroid gland, which showed a concentration five times higher than that after a single administration.4. The metabolic fate of the drug in animals receiving a subtoxic dose of the unlabelled drug for 4 weeks did not significantly differ from that in control animals.5. The faecal metabolite was identified as the deacetylated drug. Glucuronide a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Xenobiotica; the fate of foreign compounds in biological systems
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.